His medical focus is on translational research in the diagnosis and treatment of complex infections. In this context, growing resistance to antimicrobial agents is a ever-increasing global threat and often jeopardises the success of modern medical treatments. Burgmann is therefore working intensively on the preclinical and clinical development of new anti-infective agents. Amongst other things, he holds several patents for antibiotics.

The increasing importance of clinical infectology to the success of modern medical techniques should be reflected by giving greater weight to the subject within the medical curriculum. Only exceptionally well trained students will be able to cope with the challenges of constantly mutating infectious diseases.